[1]刘馥溧,巴元明△.巴元明从虚瘀毒论治肾性骨质疏松症的经验[J].中国中医骨伤科杂志,2024,32(01):85-87.[doi:10.20085/j.cnki.issn1005-0205.240116]
　LIU Fuli,BA Yuanming.Ba Yuanming's Experience of Treating Renal Osteoporosis from Deficiency,Blood Stasis and Poison[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2024,32(01):85-87.[doi:10.20085/j.cnki.issn1005-0205.240116]
点击复制

巴元明从虚瘀毒论治肾性骨质疏松症的经验()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第32卷
期数:
2024年01期
页码:
85-87
栏目:
名老中医传承
出版日期:
2024-01-15

文章信息/Info

Title:
Ba Yuanming's Experience of Treating Renal Osteoporosis from Deficiency,Blood Stasis and Poison
文章编号:
1005-0205(2024)01-0085-03
作者:
刘馥溧1; 巴元明1; 2△
1湖北中医药大学中医临床学院(武汉,430061) 2湖北中医药大学附属医院(湖北省中医院)
Author(s):
LIU Fuli1; BA Yuanming1; 2△
1Clinical School of Traditional Chinese Medicine,Hubei University of Traditional Chinese Medicine,Wuhan 430061,China; 2Affiliated Hospital of Hubei University of Chinese Medicine(Hubei Provincial Hospital of Traditional Chinese Medicine),Wuhan 430061,China.
关键词:
虚;  瘀;  毒;  肾性骨质疏松症
Keywords:
deficiency;  blood stasis;  poison;  renal osteoporosis
分类号:
R274.39
DOI:
10.20085/j.cnki.issn1005-0205.240116
文献标志码:
A
摘要:
肾性骨质疏松症是指由慢性肾脏病引起的体内矿物质和骨代谢紊乱,导致骨质疏松的疾病。本病属于继发性骨质疏松症,是慢性肾衰竭的常见并发症,严重影响患者的生活质量。巴元明教授指出,本病病性为本虚标实,本虚以肾精虚损、肝脾不足为主,标实则多见瘀血、浊毒为患,存在“病本为虚→因虚致瘀→虚瘀致毒”的病机演变规律。故临床治疗肾性骨质疏松症当以补肾强骨为主、兼扶肝脾,同时注重活血理气,化瘀通络,攻邪解毒,以达到扶正祛邪、标本兼顾的目的,从而提高慢性肾衰竭患者的生活质量。
Abstract:
Renal osteoporosis,refers to the body mineral and bone metabolism disorders caused by chronic kidney disease,leading to osteoporosis diseases.This disease is secondary osteoporosis,which is a common complication of chronic renal failure,and seriously affects the quality of life of patients.Professor Ba Yuanming pointed out that the disease nature of this disease is the deficiency,and the deficiency is mainly the deficiency of kidney essence,liver and spleen,but the fact is more blood stasis and turbidity poison.There is a pathogenesis evolution law of “the deficiency is caused by virtual stasis and blood stasis”.Therefore,the clinical treatment of renal osteoporosis should be tonifying the kidney and strengthening the liver and spleen.At the same time,more attention should be paid to promoting blood circulation and regulating Qi,removing blood stasis and dredging collaterals,so as to achieve the purpose of strengthening the healthy and removing evil and taking into account specimens,so as to improve the quality of life of patients with chronic kidney failure.

参考文献/References:

[1] 张浩,舒冰,李晓锋,等.中医“肾主骨”理论与肾性骨质疏松刍议[J].上海中医药大学学报,2020,34(6):81-87.
[2] 任之强.原发性骨质疏松症血瘀与骨代谢关系研究[J].中华中医药杂志,2015,30(5):1838-1840.
[3] 曹盼举,张晓刚,于海洋,等.基于OPG/RANK/RANKL信号轴探讨中医“瘀证”与骨质疏松症之间的关系[J].中国骨质疏松杂志,2020,26(1):114-117.
[4] 郭鱼波,王丽丽,马如风,等.骨质疏松的中医病因病机分析及其中医药治疗的前景探讨[J].世界科学技术-中医药现代化,2015,17(4):768-772.
[5] 钟雯,曹锐.筋骨辨证-筋骨并重[J].实用中医内科杂志,2017,31(2):73-76.
[6] 邓惠文.从肝脾与肾的相关性浅谈肾性骨病的诊治[J].世界最新医学信息文摘,2019,19(26):212-217.
[7] 谭旭仪,卢敏,高书图.浅析激素性股骨头坏死的“瘀、虚、痰”理论[J].中医药导报,2014,20(16):7-9.
[8] 王申,袁一峰,孙坚刚,等.骨质疏松性骨折的内毒论[J].中国中医骨伤科杂志,2021,29(3):81-84.
[9] 高子任,李跃华.中医血瘀证与骨质疏松症关系的研究[J].中华中医药杂志,2017,32(11):5154-5157.
[10] 贠清亮.论活血化瘀对扶正补虚的增效作用[J].山东中医杂志,2002(1):8-10.
[11] 邓长财,鞠中斌.从毒瘀虚辨治系统性红斑狼疮继发骨质疏松症探讨[J].江苏中医药,2012,44(6):1-2.
[12] 李玉婷,胡刚明,李伟男,等.大黄及其炮制品治疗慢性肾衰竭研究进展[J].中国中医药信息杂志,2019,26(8):137-140.
[13] 郑丽莉,高霞,朱述英,等.大黄配伍土茯苓降浊利湿在慢性肾衰竭治疗中的应用[J].中国中医基础医学杂志,2015,21(1):110-111.

备注/Memo

备注/Memo:
基金项目:2022年全国名老中医药专家传承工作室建设项目(巴元明全国名老中医药专家传承工作室)(国中医药人教函〔2022〕75号)
第六批全国老中医药专家学术经验继承工作指导老师项目(国中医药人教发〔2017〕29号)
△通信作者 E-mail:1723426138@qq.com
更新日期/Last Update: 2024-01-15